Delivering Volumetric Hyperthermia to Head and Neck Cancer Patient-Specific Models Using an Ultrasound Spherical Random Phased Array Transducer
In exploring adjuvant therapies for head and neck cancer, hyperthermia (40–45 °C) has shown efficacy in enhancing chemotherapy and radiation, as well as the delivery of liposomal drugs. Current hyperthermia treatments, however, struggle to reach large deep tumors uniformly and non-invasively. This s...
Saved in:
Main Authors: | Muhammad Zubair, Imad Uddin, Robert Dickinson, Chris J. Diederich |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-12-01
|
Series: | Bioengineering |
Subjects: | |
Online Access: | https://www.mdpi.com/2306-5354/12/1/14 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Phase II clinical trial assessing the addition of hyperthermia to salvage concurrent chemoradiotherapy for unresectable recurrent head and neck cancer in previously irradiated patients
by: Kai-Lin Yang, et al.
Published: (2025-02-01) -
Enhanced radiosensitivity of head and neck cancer cells to proton therapy via hyperthermia-induced homologous recombination deficiency
by: Tim Heemskerk, et al.
Published: (2025-03-01) -
Textbook of Head and Neck Anatomy /
by: Hiatt, James L., 1934-
Published: (2002) -
Prognostic Factors of Liposarcoma in Head and Neck
by: Shuo DING, et al.
Published: (2025-01-01) -
A systematic review of social impacts of treatment and rehabilitation of head and neck cancer patients
by: Rebecca T. Bernstein, et al.
Published: (2025-03-01)